HAL Allergy Group
1959
FOUNDED
PRIVATE
STATUS
201-300
EMPLOYEES
Buyout/LBO
LATEST DEAL TYPE
2
FINANCING ROUNDS
Description
Manufacturer and distributor of bio pharmaceutical products. The company develops and produces vaccines, allergy detection and treatment products. It specialises in Immunotherapy, desensitization and therapeutic treatment of all allergies caused by trees, grass pollens and mites with the help of preparations that can be administered orally and subcutaneously.
Website
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Distributors (Healthcare)
Pharmaceuticals
Primary Office
- J.H. Oortweg 15-17
- 2333 CH Leiden
- Netherlands
+31 088 000 0000
HAL Allergy Group Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore HAL Allergy Group‘s full profile, request access.
Request full access to PitchBookHAL Allergy Group Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore HAL Allergy Group‘s full profile, request access.
Request full access to PitchBookHAL Allergy Group Executive Team (6)
1 Former Executive
You’re viewing 5 of 6 executives. Get the full list »HAL Allergy Group Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 0000 000 000000000 | HAL Allergy Group | Chief Scientific Officer & Board Member | 000 0000 | |
| 0000 00 0000 00.0 | HAL Allergy Group | Chief Operating Officer & Board Member | 000 0000 | |
| 0000000 0ö000 | HAL Allergy Group | Chief Commercial & Financial Officer & Board Member | 000 0000 |